Journals / Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi / 2011 / Cilt: 14 - Sayı: 2

The Relationship of Rheumatoid Factor Izotypes with Prognosis of Disease in Patients with Rheumatoid Arthritis

Romatoid Artritli Hastalarda Romatoid Faktör İzotiplerinin Hastalık Prognozuyla İlişkisi

Pages
43–47
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When the patients were grouped according to the severity of disease activity, functional impairment, radiological joint damage, and thepresence of extra- articular involvement, there was no statistically significant difference between the groups regarding autoantibody levels (P>0.05).Conclusion:Though some of them have high specificities like anti- CCP and RF- IgM, these autoantibodies were not found effective in predicting the prognosis so we suggest that, aggressive treatment should be planned as far as RA is diagnosed without taking the presence ofthe autoantibodies into account.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the study was to search the relationship of rheumatoid factor (RF) isotypes and anti- cyclic citrullinated peptide (anti- CCP) with disease activity, radiological joint damage, functional impairment and extra- articular involvement in patients with rheumatoid arthritis (RA).Materials and Methods:Volunteer 45 patients with RA and 41 patients with knee osteoarthritis were included in the study.
📊
Key Findings & Data:Results: Anti- CCP and RF were found 71.1 % and 57.8%, respectively in patients with RA.
💡
Conclusion & Impact:When the patients were grouped according to the severity of disease activity, functional impairment, radiological joint damage, and thepresence of extra- articular involvement, there was no statistically significant difference between the groups regarding autoantibody levels (P>0.05).Conclusion:Though some of them have high specificities like anti- CCP and RF- IgM, these autoantibodies were not found effective in predicting the prognosis so we suggest that, aggressive treatment should be planned as far as RA is diagnosed without taking the presence ofthe autoantibodies into account.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of the study was to search the relationship of rheumatoid factor (RF) isotypes and anti- cyclic citrullinated peptide (anti- CCP) with disease activity, radiological joint damage, functional impairment and extra- articular involvement in patients with rheumatoid arthritis (RA).Materials and Methods:Volunteer 45 patients with RA and 41 patients with knee osteoarthritis were included in the study. RF, RF isotypes (RF- IgA, RF- IgG, IgM), anti- CCP and acute phase reactants werestudied in all subjects. Disease activity, radiological joint damage, functional impairment and extra- articularinvolvement were evaluated in patients with RA. Results: Anti- CCP and RF were found 71.1 % and 57.8%, respectively in patients with RA. RF- IgM, the mostfrequent RF isotype, was found in 66.7% of patients. The specificities of RF and anti- CCP were 98% and werehigher than the specificities of RF isotypes for the diagnosis of the disease. The sensitivity of anti- CCP was thehighest with a ratio of 71%. Sensitivities of RF, RF- IgM, RF- IgA and RF- IgG were 58%, 67%, 42% and 53% respectively. When the patients were grouped according to the severity of disease activity, functional impairment, radiological joint damage, and thepresence of extra- articular involvement, there was no statistically significant difference between the groups regarding autoantibody levels (P>0.05).Conclusion:Though some of them have high specificities like anti- CCP and RF- IgM, these autoantibodies were not found effective in predicting the prognosis so we suggest that, aggressive treatment should be planned as far as RA is diagnosed without taking the presence ofthe autoantibodies into account.

Özet

Amaç: Bu çalışmanın amacı RA'li hastalarda hastalık aktivitesi, radyolojik eklem hasarı, fonksiyonel bozukluk veekstraartiküler tutulum ile RF izotipleri ve Siklik Sitrulin Peptit antikoru (anti- CCP) arasındaki ilişkiyi araştırmaktır.Materyal ve Metod: Çalışmaya RA tanılı 45 gönüllü hasta ile diz osteoartrit tanılı 41 gönüllü hasta dahil edildi.Çalışmaya alınan tüm olguların akut faz reaktantları, RF, RF izotipleri (RF- IgA, RF- IgG, RF- IgM) ve anti- CCPdeğerleri çalışıldı. RA' lı hastalarda hastalık aktivitesi, radyolojik eklem hasarı, fonksiyonel bozukluk ve ekstraartiküler tutulum değerlendirildi.Bulgular: RA'lı hasta grubunda anti- CCP %71,1'lik oranla ve RF %57,8'lik oranla pozitif bulundu. RF- IgM, ensık gözlenen RF izotipi olup, RA'lı hastaların % 66,7'de pozitif bulundu. RA tanısı için RF ve anti- CCP'nin özgüllüğü %98'di ve RF izotiplerinin özgüllüğünden yüksekti. Anti- CCP'nin duyarlılığı %71'lik oranla en yüksekti. RF,RF- IgM RF- IgA ve RF- IgG'nin duyarlılıkları sırayla %58, %67, %42 ve %53'dü. RA'lı hasta grubu hastalıkaktivitesi, fonksiyonel bozukluk, radyolojik eklem hasarı ve ekstraartiküler tutulum varlığına göre gruplandırıldığında otoantikor değerleri açısından gruplar arasında istatistiksel olarak anlamlı bir fark yoktu (P>0.05).Sonuçlar: Anti- CCP ve RF- IgM, RA tanısı için yüksek özgüllüğe sahip olsalar da, otoantikorlar hastalık prognozunu belirlemede etkili bulunmamışlardır. Bu nedenle hastalık tanısı konulduğunda otoantikor pozitifliğinigözönünde bulundurmaksızın tedavinin planlanması gerektiğini düşünmekteyiz

🔖

Cite This Article

ŞAŞ, S., ŞAHİN, Ö., ELDEN, H., HAYTA, E., KAPTANOĞLU, E. (2011). The Relationship of Rheumatoid Factor Izotypes with Prognosis of Disease in Patients with Rheumatoid Arthritis. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi, Cilt: 14 - Sayı: 2, 43–47. https://ajindex.com/articles/210855

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Waldburger JM, Firestein GS. Rheumatoid arthritis:Epidemiology, Pathology, and Pathogenesis. In: Klippel JH,Stone JH, Crofford LJ, White PH editors. Primer on theRheumatic Disease. New York: Spriger, 2008
  2. Arnett FC, Edworthy SM, Bloch DA, et al. The AmericanRheumatism Association 1987 revised criteria for the classificationof rheumatoid arthritis. Arthritis Rheum 1988
  3. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritisclassification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.Arthritis Rheum 2010
  4. Ateş A, Kinikli G, Turgay M, Akay G, Tokgöz G. Effects of rheumatoid factor isotypes on disease activity and severity inpatients with rheumatoid arthritis: a comparative study. ClinRheumatol 2007
  5. Teitsson I, Withrington RH, Seifert MH, Valdimarsson H.Prospective study of early rheumatoid arthritis. I. Prognosticvalue of IgA rheumatoid factor. Ann Rheum Dis 1984
  6. Gioud- Paquet M, Auvinet M, Raffin T, et al. IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA inrheumatoid arthritis. Ann Rheum Dis 1987
  7. Vallbracht I, Rieber J, Oppermann M, Förger F, Siebert U,Helmke K. Diagnostic and clinical value of anti- cyclic citrullinatedpeptide antibodies compared with rheumatoid factor isotypesin rheumatoid arthritis. Ann Rheum Dis 2004
  8. Bas S, Genevay S, Meyer O, Gabay C. Anti-cyclic citrullinatedpeptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology(Oxford) 2003
  9. Luthviksson BR, Jonsson T, Erlendsson K, Sigfusson A.Disease manifestations in patients with isolated elevation of IgArheumatoid factor. Scand J Rheumatol 1992
  10. Li H, Song W, Li Y, et al. Diagnostic value of anti- cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity. Clin Rheumatol 2010
  11. Mathsson L, Mullazehi M, Wick MC, et al. Antibodies againstcitrullinated vimentin in rheumatoid arthritis: higher sensitivityand extended prognostic value concerning future radiographicprogression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum 2008
  12. Ursum J, Nielen MM, van Schaardenburg D, et al. Antibodies tomutated citrullinated vimentin and disease activity score in earlyarthritis: a cohort study. Arthrit